Stock 301033 MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Medprin Regenerative Medical Technologies Co., Ltd.

Equities

301033

CNE100004NB8

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-23 pm EDT 		5-day change 1st Jan Change
40.21 CNY -2.71% Intraday chart for Medprin Regenerative Medical Technologies Co., Ltd. -3.76% -7.65%
Apr. 24 Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 18 Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 2,436 2,876 2,656 -
Enterprise Value (EV) 1 2,436 2,876 2,656 2,656
P/E ratio 68.3 x 70.2 x 39 x 25.3 x
Yield - - - -
Capitalization / Revenue - 12.5 x 9.22 x 7.05 x
EV / Revenue - 12.5 x 9.22 x 7.05 x
EV / EBITDA - 39.9 x 28.4 x 20 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - 4.52 x 3.83 x 3.42 x
Nbr of stocks (in thousands) 66,063 66,063 66,063 -
Reference price 2 36.88 43.54 40.21 40.21
Announcement Date 4/26/23 4/18/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 230.9 288 376.8
EBITDA 1 - 72.17 93.42 132.6
EBIT 1 - 48.27 74.14 116.6
Operating Margin - 20.91% 25.74% 30.93%
Earnings before Tax (EBT) 1 - 48.02 77.46 119.8
Net income 1 35.89 40.88 67.76 105.3
Net margin - 17.71% 23.53% 27.95%
EPS 2 0.5400 0.6200 1.030 1.590
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 4/26/23 4/18/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - 6.63% 9.77% 13.6%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - 9.630 10.50 11.80
Cash Flow per Share 2 - 1.630 0.7700 2.340
Capex - - - 1.35
Capex / Sales - - - 0.36%
Announcement Date 4/26/23 4/18/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Medprin Regenerative Medical Technologies Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
40.21
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD. Stock Medprin Regenerative Medical Technologies Co., Ltd.
-7.65% 367M
STRYKER CORPORATION Stock Stryker Corporation
+12.05% 128B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-9.24% 10.88B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+0.29% 8.76B
GLAUKOS CORPORATION Stock Glaukos Corporation
+36.99% 5.48B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-21.98% 4.72B
AXONICS, INC. Stock Axonics, Inc.
+8.02% 3.43B
ENOVIS CORPORATION Stock Enovis Corporation
-10.32% 2.76B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-12.33% 2.06B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-13.53% 1.92B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. 301033 Stock
  4. Financials Medprin Regenerative Medical Technologies Co., Ltd.